SCHEMBL4194411

SCHEMBL4194411

Nc1c(C(=O)Nc2ncccc2Cl)oc2ccccc12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 11/20 0.60
▸ RAB9A P51151 10/20 0.60
▸ KDM4E B2RXH2 4/20 0.60
▸ MAPT P10636 3/20 0.60
▸ HPGD P15428 2/20 0.60
▸ USP2 O75604 2/20 0.60
▸ HTT P42858 2/20 0.60
▸ ALDH1A1 P00352 1/20 0.60
▸ NFKB1 P19838 1/20 0.60
▸ NFKB2 Q00653 1/20 0.60
▸ RELA Q04206 1/20 0.60
▸ RXFP1 Q9HBX9 1/20 0.52
▸ SMN1; SMN2 Q16637 5/20 0.48
▸ POLB P06746 1/20 0.48
▸ TP53 P04637 1/20 0.47
▸ ATM Q13315 1/20 0.47
▸ KMT2A Q03164 2/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ TSHR P16473 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2945692 0.76 SMN1; SMN2 (0.74) NPC1RAB9AKDM4EMAPTHPGD
SCHEMBL13665173 0.76 MAPT (1.00) NPC1RAB9AKDM4EMAPTHPGD
SCHEMBL13743910 0.74 NPC1 (0.79) NPC1RAB9AKDM4EMAPTHPGD
SCHEMBL10372228 0.72 NPC1 (0.55) NPC1RAB9AKDM4EMAPTHPGD
SCHEMBL13665172 0.72 RAB9A (0.58) NPC1RAB9AKDM4EMAPTHPGD
SCHEMBL23566394 0.71 USP2 (0.68) NPC1RAB9AUSP2HTTALDH1A1
SCHEMBL13515787 0.71 RAB9A (0.78) NPC1RAB9AKDM4EMAPTHPGD
SCHEMBL13515767 0.70 MAPT (0.76) NPC1RAB9AKDM4EMAPTHPGD
SCHEMBL13665178 0.70 MAPT (0.76) NPC1RAB9AKDM4EMAPTHPGD
SCHEMBL13665176 0.70 MAPT (0.76) NPC1RAB9AKDM4EMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090209511-A1 Benzofuran Derivatives KAWAGUCHI TAKAYUKI 2009-08-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090209511-A1 Benzofuran Derivatives F12, F2, F3 NPC1 3431/4885RAB9A 4600/4885KDM4E 1464/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback